BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25152163)

  • 1. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease.
    Rådmark O; Werz O; Steinhilber D; Samuelsson B
    Biochim Biophys Acta; 2015 Apr; 1851(4):331-9. PubMed ID: 25152163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis.
    Rådmark O; Samuelsson B
    Biochem Biophys Res Commun; 2010 May; 396(1):105-10. PubMed ID: 20494120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures and mechanisms of enzymes in the leukotriene cascade.
    Rinaldo-Matthis A; Haeggström JZ
    Biochimie; 2010 Jun; 92(6):676-81. PubMed ID: 20097252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene inflammatory mediators meet their match.
    Funk CD
    Sci Transl Med; 2011 Jan; 3(66):66ps3. PubMed ID: 21248314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitors of 5-lipoxygenase].
    Gápovský M; Remko M
    Ceska Slov Farm; 2002 Mar; 51(2):55-62. PubMed ID: 11928277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activity.
    Rakonjac Ryge M; Tanabe M; Provost P; Persson B; Chen X; Funk CD; Rinaldo-Matthis A; Hofmann B; Steinhilber D; Watanabe T; Samuelsson B; Rådmark O
    Arch Biochem Biophys; 2014 Mar; 545():179-85. PubMed ID: 24480307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in eicosanoid research, novel therapeutic implications.
    Haeggström JZ; Rinaldo-Matthis A; Wheelock CE; Wetterholm A
    Biochem Biophys Res Commun; 2010 May; 396(1):135-9. PubMed ID: 20494126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Lipoxygenase: regulation of expression and enzyme activity.
    Rådmark O; Werz O; Steinhilber D; Samuelsson B
    Trends Biochem Sci; 2007 Jul; 32(7):332-41. PubMed ID: 17576065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modulation of leukotriene pathway - potential targets].
    Peter H; Lýdia B
    Ceska Slov Farm; 2012 Jun; 61(3):101-6. PubMed ID: 22913825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced lipoxygenase and cyclooxygenase mediated signaling in PBMC of atopic dermatitis patients.
    Mihály J; Gericke J; Törőcsik D; Gáspár K; Szegedi A; Rühl R
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():35-42. PubMed ID: 23603610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased PUFA Content and 5-Lipoxygenase Pathway Expression Are Associated with Subcutaneous Adipose Tissue Inflammation in Obese Women with Type 2 Diabetes.
    Heemskerk MM; Giera M; Bouazzaoui FE; Lips MA; Pijl H; van Dijk KW; van Harmelen V
    Nutrients; 2015 Sep; 7(9):7676-90. PubMed ID: 26378572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-lipoxygenase: regulation and possible involvement in atherosclerosis.
    Rådmark O; Samuelsson B
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):162-74. PubMed ID: 17481551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Lipoxygenase: mechanisms of regulation.
    Rådmark O; Samuelsson B
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S40-5. PubMed ID: 18987389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach.
    Sinha S; Doble M; Manju SL
    Bioorg Med Chem; 2019 Sep; 27(17):3745-3759. PubMed ID: 31331653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotrienes in pulmonary arterial hypertension.
    Tian W; Jiang X; Sung YK; Qian J; Yuan K; Nicolls MR
    Immunol Res; 2014 May; 58(2-3):387-93. PubMed ID: 24570092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of propofol hydroxyl group in 5-lipoxygenase recognition.
    Yuki K; Bu W; Eckenhoff RG; Yokomizo T; Okuno T
    Biochem Biophys Res Commun; 2020 May; 525(4):909-914. PubMed ID: 32171526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity.
    Burnett BP; Levy RM
    Adv Ther; 2012 Feb; 29(2):79-98. PubMed ID: 22351432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
    Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D
    Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location, location, location: compartmentalization of early events in leukotriene biosynthesis.
    Newcomer ME; Gilbert NC
    J Biol Chem; 2010 Aug; 285(33):25109-14. PubMed ID: 20507998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the enzymes in the leukotriene and prostaglandin pathways in inflammation by 3-aryl isocoumarins.
    Ramanan M; Sinha S; Sudarshan K; Aidhen IS; Doble M
    Eur J Med Chem; 2016 Nov; 124():428-434. PubMed ID: 27597418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.